Certoparin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Certoparin
Accession Number
DB09261
Type
Small Molecule
Groups
Approved, Investigational
Description

Certoparin is a low molecular weight heparin, primarily active against factor Xa. Like other low molecular weight heparins, it is used to prevent deep venous thrombosis.

Synonyms
Not Available
International/Other Brands
Embolex / Sandoparin
Categories
UNII
V72OT3K19I
CAS number
Not Available
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication

Used in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.

Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
(4R)-limonene(4R)-limonene may increase the anticoagulant activities of Certoparin.Investigational
AbciximabAbciximab may increase the anticoagulant activities of Certoparin.Approved
AceclofenacAceclofenac may increase the anticoagulant activities of Certoparin.Approved, Investigational
AcemetacinThe risk or severity of bleeding can be increased when Certoparin is combined with Acemetacin.Approved, Experimental, Investigational
AcenocoumarolAcenocoumarol may increase the anticoagulant activities of Certoparin.Approved, Investigational
Acetylsalicylic acidAcetylsalicylic acid may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
AdapaleneAdapalene may increase the anticoagulant activities of Certoparin.Approved
AlclofenacAlclofenac may increase the anticoagulant activities of Certoparin.Approved, Withdrawn
AliskirenCertoparin may increase the hyperkalemic activities of Aliskiren.Approved, Investigational
AllylestrenolThe therapeutic efficacy of Certoparin can be decreased when used in combination with Allylestrenol.Approved
AlminoprofenAlminoprofen may increase the anticoagulant activities of Certoparin.Experimental
AloxiprinAloxiprin may increase the anticoagulant activities of Certoparin.Experimental
AlprostadilAlprostadil may increase the anticoagulant activities of Certoparin.Approved, Investigational
AlteplaseAlteplase may increase the anticoagulant activities of Certoparin.Approved
AltrenogestThe therapeutic efficacy of Certoparin can be decreased when used in combination with Altrenogest.Vet Approved
AmilorideCertoparin may increase the hyperkalemic activities of Amiloride.Approved
Aminosalicylic AcidAminosalicylic Acid may increase the anticoagulant activities of Certoparin.Approved
AnagrelideAnagrelide may increase the anticoagulant activities of Certoparin.Approved
AncrodAncrod may increase the anticoagulant activities of Certoparin.Approved, Investigational
AndrographolideAndrographolide may increase the anticoagulant activities of Certoparin.Investigational
AnisodamineAnisodamine may increase the anticoagulant activities of Certoparin.Investigational
AnistreplaseAnistreplase may increase the anticoagulant activities of Certoparin.Approved
AntipyrineAntipyrine may increase the anticoagulant activities of Certoparin.Approved, Investigational
Antithrombin III humanCertoparin may increase the anticoagulant activities of Antithrombin III human.Approved
ApixabanApixaban may increase the anticoagulant activities of Certoparin.Approved
ApocyninApocynin may increase the anticoagulant activities of Certoparin.Investigational
ApremilastApremilast may increase the anticoagulant activities of Certoparin.Approved, Investigational
ArdeparinArdeparin may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
ArgatrobanArgatroban may increase the anticoagulant activities of Certoparin.Approved, Investigational
AstaxanthinAstaxanthin may increase the anticoagulant activities of Certoparin.Investigational
AzapropazoneAzapropazone may increase the anticoagulant activities of Certoparin.Withdrawn
AzelastineAzelastine may increase the anticoagulant activities of Certoparin.Approved
Azficel-TThe risk or severity of adverse effects can be increased when Certoparin is combined with Azficel-T.Approved, Investigational
Azilsartan medoxomilCertoparin may increase the hyperkalemic activities of Azilsartan medoxomil.Approved, Investigational
BalsalazideBalsalazide may increase the anticoagulant activities of Certoparin.Approved, Investigational
BatroxobinBatroxobin may increase the anticoagulant activities of Certoparin.Experimental
BecaplerminBecaplermin may increase the anticoagulant activities of Certoparin.Approved, Investigational
BemiparinBemiparin may increase the anticoagulant activities of Certoparin.Approved, Investigational
BendazacBendazac may increase the anticoagulant activities of Certoparin.Experimental
BenorilateBenorilate may increase the anticoagulant activities of Certoparin.Experimental
BenoxaprofenBenoxaprofen may increase the anticoagulant activities of Certoparin.Withdrawn
BenzydamineBenzydamine may increase the anticoagulant activities of Certoparin.Approved
BeraprostBeraprost may increase the anticoagulant activities of Certoparin.Investigational
BevoniumBevonium may increase the anticoagulant activities of Certoparin.Experimental
BivalirudinBivalirudin may increase the anticoagulant activities of Certoparin.Approved, Investigational
BrinaseBrinase may increase the anticoagulant activities of Certoparin.Experimental
BromfenacBromfenac may increase the anticoagulant activities of Certoparin.Approved
BucillamineBucillamine may increase the anticoagulant activities of Certoparin.Investigational
BufexamacBufexamac may increase the anticoagulant activities of Certoparin.Approved, Experimental
BuflomedilBuflomedil may increase the anticoagulant activities of Certoparin.Experimental
BumadizoneBumadizone may increase the anticoagulant activities of Certoparin.Experimental
ButylphthalideButylphthalide may increase the anticoagulant activities of Certoparin.Investigational
CanagliflozinCertoparin may increase the hyperkalemic activities of Canagliflozin.Approved
CandesartanCertoparin may increase the hyperkalemic activities of Candesartan.Experimental
Candesartan cilexetilCertoparin may increase the hyperkalemic activities of Candesartan cilexetil.Approved
CangrelorCangrelor may increase the anticoagulant activities of Certoparin.Approved
CaplacizumabCaplacizumab may increase the anticoagulant activities of Certoparin.Investigational
Carbaspirin calciumCarbaspirin calcium may increase the anticoagulant activities of Certoparin.Experimental, Investigational
CarprofenCarprofen may increase the anticoagulant activities of Certoparin.Approved, Vet Approved, Withdrawn
CastanospermineCastanospermine may increase the anticoagulant activities of Certoparin.Experimental
CelecoxibCelecoxib may increase the anticoagulant activities of Certoparin.Approved, Investigational
ChloroquineChloroquine may increase the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
ChlorotrianiseneChlorotrianisene may decrease the anticoagulant activities of Certoparin.Investigational, Withdrawn
Choline magnesium trisalicylateCholine magnesium trisalicylate may increase the anticoagulant activities of Certoparin.Approved
CilostazolCilostazol may increase the anticoagulant activities of Certoparin.Approved, Investigational
Citric AcidCitric Acid may increase the anticoagulant activities of Certoparin.Approved, Nutraceutical, Vet Approved
ClonixinClonixin may increase the anticoagulant activities of Certoparin.Approved
ClopidogrelClopidogrel may increase the anticoagulant activities of Certoparin.Approved
CloricromenCloricromen may increase the anticoagulant activities of Certoparin.Experimental
ClorindioneClorindione may increase the anticoagulant activities of Certoparin.Experimental
Collagenase clostridium histolyticumThe risk or severity of adverse effects can be increased when Certoparin is combined with Collagenase clostridium histolyticum.Approved, Investigational
Conjugated estrogensConjugated estrogens may decrease the anticoagulant activities of Certoparin.Approved
CurcuminCurcumin may increase the anticoagulant activities of Certoparin.Approved, Investigational
Dabigatran etexilateDabigatran etexilate may increase the anticoagulant activities of Certoparin.Approved
DaidzeinDaidzein may decrease the anticoagulant activities of Certoparin.Experimental
DalteparinDalteparin may increase the anticoagulant activities of Certoparin.Approved
DanaparoidDanaparoid may increase the anticoagulant activities of Certoparin.Approved, Withdrawn
DarexabanCertoparin may increase the anticoagulant activities of Darexaban.Investigational
DasatinibDasatinib may increase the anticoagulant activities of Certoparin.Approved, Investigational
DeferasiroxThe risk or severity of adverse effects can be increased when Certoparin is combined with Deferasirox.Approved, Investigational
DefibrotideDefibrotide may increase the anticoagulant activities of Certoparin.Approved, Investigational
DemegestoneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Demegestone.Experimental
Deoxycholic AcidThe risk or severity of adverse effects can be increased when Certoparin is combined with Deoxycholic Acid.Approved
DersalazineDersalazine may increase the anticoagulant activities of Certoparin.Investigational
DesirudinCertoparin may increase the anticoagulant activities of Desirudin.Approved
DesmoteplaseDesmoteplase may increase the anticoagulant activities of Certoparin.Investigational
DesogestrelThe therapeutic efficacy of Certoparin can be decreased when used in combination with Desogestrel.Approved
DextranDextran may increase the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
DiclofenacDiclofenac may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
DicoumarolDicoumarol may increase the anticoagulant activities of Certoparin.Approved
DienestrolDienestrol may decrease the anticoagulant activities of Certoparin.Approved, Investigational
DienogestThe therapeutic efficacy of Certoparin can be decreased when used in combination with Dienogest.Approved
DiethylstilbestrolDiethylstilbestrol may decrease the anticoagulant activities of Certoparin.Approved, Investigational
DifenpiramideDifenpiramide may increase the anticoagulant activities of Certoparin.Experimental
DiflunisalDiflunisal may increase the anticoagulant activities of Certoparin.Approved, Investigational
DiphenadioneDiphenadione may increase the anticoagulant activities of Certoparin.Experimental
DipyridamoleDipyridamole may increase the anticoagulant activities of Certoparin.Approved
DitazoleDitazole may increase the anticoagulant activities of Certoparin.Approved, Withdrawn
Drotrecogin alfaDrotrecogin alfa may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
DroxicamDroxicam may increase the anticoagulant activities of Certoparin.Withdrawn
DuvelisibDuvelisib may increase the anticoagulant activities of Certoparin.Investigational
DydrogesteroneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Dydrogesterone.Approved, Investigational, Withdrawn
E-6201E-6201 may increase the anticoagulant activities of Certoparin.Investigational
Edetic AcidEdetic Acid may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
EdoxabanEdoxaban may increase the anticoagulant activities of Certoparin.Approved
EnoxaparinEnoxaparin may increase the anticoagulant activities of Certoparin.Approved
EpimestrolEpimestrol may decrease the anticoagulant activities of Certoparin.Experimental
EpinastineEpinastine may increase the anticoagulant activities of Certoparin.Approved, Investigational
EpirizoleEpirizole may increase the anticoagulant activities of Certoparin.Approved
EplerenoneCertoparin may increase the hyperkalemic activities of Eplerenone.Approved
EplivanserinEplivanserin may increase the anticoagulant activities of Certoparin.Investigational
eplivanserineeplivanserine may increase the anticoagulant activities of Certoparin.Investigational
EpoprostenolEpoprostenol may increase the anticoagulant activities of Certoparin.Approved
EprosartanCertoparin may increase the hyperkalemic activities of Eprosartan.Approved
EptifibatideEptifibatide may increase the anticoagulant activities of Certoparin.Approved, Investigational
EquolEquol may decrease the anticoagulant activities of Certoparin.Investigational
EstradiolEstradiol may decrease the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
Estradiol acetateEstradiol acetate may decrease the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
Estradiol cypionateEstradiol cypionate may decrease the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
Estradiol valerateEstradiol valerate may decrease the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
EstriolEstriol may decrease the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
Estrogens, esterifiedEstrogens, esterified may decrease the anticoagulant activities of Certoparin.Approved
EstroneEstrone may decrease the anticoagulant activities of Certoparin.Approved
EtanerceptEtanercept may increase the anticoagulant activities of Certoparin.Approved, Investigational
EthenzamideEthenzamide may increase the anticoagulant activities of Certoparin.Experimental
Ethinyl EstradiolEthinyl Estradiol may decrease the anticoagulant activities of Certoparin.Approved
Ethyl biscoumacetateEthyl biscoumacetate may increase the anticoagulant activities of Certoparin.Withdrawn
EthynodiolThe therapeutic efficacy of Certoparin can be decreased when used in combination with Ethynodiol.Experimental
EtodolacEtodolac may increase the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
EtofenamateEtofenamate may increase the anticoagulant activities of Certoparin.Approved, Investigational
EtonogestrelThe therapeutic efficacy of Certoparin can be decreased when used in combination with Etonogestrel.Approved, Investigational
EtoricoxibEtoricoxib may increase the anticoagulant activities of Certoparin.Approved, Investigational
Evening primrose oilEvening primrose oil may increase the anticoagulant activities of Certoparin.Investigational, Nutraceutical
ExisulindExisulind may increase the anticoagulant activities of Certoparin.Investigational
FelbinacFelbinac may increase the anticoagulant activities of Certoparin.Experimental
FenbufenFenbufen may increase the anticoagulant activities of Certoparin.Approved
FenoprofenFenoprofen may increase the anticoagulant activities of Certoparin.Approved
FentiazacFentiazac may increase the anticoagulant activities of Certoparin.Experimental
FeprazoneFeprazone may increase the anticoagulant activities of Certoparin.Experimental
Ferulic acidFerulic acid may increase the anticoagulant activities of Certoparin.Experimental
FibrinolysinFibrinolysin may increase the anticoagulant activities of Certoparin.Investigational
FimasartanCertoparin may increase the hyperkalemic activities of Fimasartan.Approved, Investigational
FloctafenineFloctafenine may increase the anticoagulant activities of Certoparin.Approved, Withdrawn
FluindioneCertoparin may increase the anticoagulant activities of Fluindione.Approved, Investigational
FlunixinFlunixin may increase the anticoagulant activities of Certoparin.Vet Approved
FlunoxaprofenFlunoxaprofen may increase the anticoagulant activities of Certoparin.Experimental
FlurbiprofenFlurbiprofen may increase the anticoagulant activities of Certoparin.Approved, Investigational
FondaparinuxCertoparin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Fondaparinux sodiumFondaparinux sodium may increase the anticoagulant activities of Certoparin.Approved, Investigational
ForasartanCertoparin may increase the hyperkalemic activities of Forasartan.Experimental
GabexateCertoparin may increase the anticoagulant activities of Gabexate.Investigational
GenisteinGenistein may decrease the anticoagulant activities of Certoparin.Investigational
GestodeneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Gestodene.Approved, Investigational
GestonoroneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Gestonorone.Experimental
GestrinoneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Gestrinone.Approved
GuacetisalGuacetisal may increase the anticoagulant activities of Certoparin.Experimental
HeminHemin may increase the anticoagulant activities of Certoparin.Approved, Investigational
Hemoglobin crosfumarilHemoglobin crosfumaril may increase the anticoagulant activities of Certoparin.Experimental
HeparinHeparin may increase the anticoagulant activities of Certoparin.Approved, Investigational
HexestrolHexestrol may decrease the anticoagulant activities of Certoparin.Withdrawn
HigenamineHigenamine may increase the anticoagulant activities of Certoparin.Investigational
Hydroxyprogesterone caproateThe therapeutic efficacy of Certoparin can be decreased when used in combination with Hydroxyprogesterone caproate.Approved, Investigational
HydroxytyrosolHydroxytyrosol may increase the anticoagulant activities of Certoparin.Investigational
Ibritumomab tiuxetanThe risk or severity of adverse effects can be increased when Certoparin is combined with Ibritumomab tiuxetan.Approved, Investigational
IbrutinibThe risk or severity of adverse effects can be increased when Ibrutinib is combined with Certoparin.Approved
IbudilastIbudilast may increase the anticoagulant activities of Certoparin.Approved, Investigational
IbuprofenIbuprofen may increase the anticoagulant activities of Certoparin.Approved
IbuproxamIbuproxam may increase the anticoagulant activities of Certoparin.Withdrawn
IcatibantIcatibant may increase the anticoagulant activities of Certoparin.Approved, Investigational
Icosapent ethylIcosapent ethyl may increase the anticoagulant activities of Certoparin.Approved, Investigational, Nutraceutical
IdraparinuxIdraparinux may increase the anticoagulant activities of Certoparin.Investigational
IfenprodilIfenprodil may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
IfetrobanIfetroban may increase the anticoagulant activities of Certoparin.Investigational
IloprostIloprost may increase the anticoagulant activities of Certoparin.Approved, Investigational
Imidazole salicylateImidazole salicylate may increase the anticoagulant activities of Certoparin.Experimental
IndobufenIndobufen may increase the anticoagulant activities of Certoparin.Investigational
IndomethacinIndomethacin may increase the anticoagulant activities of Certoparin.Approved, Investigational
IndoprofenIndoprofen may increase the anticoagulant activities of Certoparin.Withdrawn
IrbesartanCertoparin may increase the hyperkalemic activities of Irbesartan.Approved, Investigational
IsoxicamIsoxicam may increase the anticoagulant activities of Certoparin.Withdrawn
KebuzoneKebuzone may increase the anticoagulant activities of Certoparin.Experimental
KetanserinKetanserin may increase the anticoagulant activities of Certoparin.Investigational
KetoprofenKetoprofen may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
KetorolacKetorolac may increase the anticoagulant activities of Certoparin.Approved
LeflunomideLeflunomide may increase the anticoagulant activities of Certoparin.Approved, Investigational
LepirudinLepirudin may increase the anticoagulant activities of Certoparin.Approved
LetaxabanCertoparin may increase the anticoagulant activities of Letaxaban.Investigational
LevonorgestrelThe therapeutic efficacy of Certoparin can be decreased when used in combination with Levonorgestrel.Approved, Investigational
LimaprostThe risk or severity of adverse effects can be increased when Limaprost is combined with Certoparin.Approved, Investigational
LinsidomineLinsidomine may increase the anticoagulant activities of Certoparin.Experimental
LisofyllineLisofylline may increase the anticoagulant activities of Certoparin.Investigational
LonazolacLonazolac may increase the anticoagulant activities of Certoparin.Experimental
LornoxicamLornoxicam may increase the anticoagulant activities of Certoparin.Approved, Investigational
LosartanCertoparin may increase the hyperkalemic activities of Losartan.Approved
LoxoprofenLoxoprofen may increase the anticoagulant activities of Certoparin.Approved, Investigational
LumiracoxibLumiracoxib may increase the anticoagulant activities of Certoparin.Approved, Investigational
Magnesium salicylateMagnesium salicylate may increase the anticoagulant activities of Certoparin.Approved
MasoprocolMasoprocol may increase the anticoagulant activities of Certoparin.Approved, Investigational
Meclofenamic acidMeclofenamic acid may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
MedrogestoneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Medrogestone.Approved
Medroxyprogesterone acetateThe therapeutic efficacy of Certoparin can be decreased when used in combination with Medroxyprogesterone acetate.Approved, Investigational
Mefenamic acidMefenamic acid may increase the anticoagulant activities of Certoparin.Approved
Megestrol acetateThe therapeutic efficacy of Certoparin can be decreased when used in combination with Megestrol acetate.Approved, Investigational, Vet Approved
MelagatranCertoparin may increase the anticoagulant activities of Melagatran.Experimental
MeloxicamMeloxicam may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
MesalazineMesalazine may increase the anticoagulant activities of Certoparin.Approved
MestranolMestranol may decrease the anticoagulant activities of Certoparin.Approved
MetamizoleMetamizole may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
MethallenestrilMethallenestril may decrease the anticoagulant activities of Certoparin.Experimental
Methyl salicylateMethyl salicylate may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
MethylestrenoloneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Methylestrenolone.Experimental
MilrinoneMilrinone may increase the anticoagulant activities of Certoparin.Approved
MizoribineMizoribine may increase the anticoagulant activities of Certoparin.Investigational
MofebutazoneMofebutazone may increase the anticoagulant activities of Certoparin.Experimental
MoxestrolMoxestrol may decrease the anticoagulant activities of Certoparin.Experimental
Mycophenolate mofetilMycophenolate mofetil may increase the anticoagulant activities of Certoparin.Approved, Investigational
Mycophenolic acidMycophenolic acid may increase the anticoagulant activities of Certoparin.Approved
NabumetoneNabumetone may increase the anticoagulant activities of Certoparin.Approved
NadroparinNadroparin may increase the anticoagulant activities of Certoparin.Approved, Investigational
NafamostatNafamostat may increase the anticoagulant activities of Certoparin.Approved, Investigational
NaftifineNaftifine may increase the anticoagulant activities of Certoparin.Approved
NaftopidilNaftopidil may increase the anticoagulant activities of Certoparin.Investigational
NaproxenNaproxen may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
NepafenacNepafenac may increase the anticoagulant activities of Certoparin.Approved, Investigational
NifenazoneNifenazone may increase the anticoagulant activities of Certoparin.Experimental
Niflumic AcidNiflumic Acid may increase the anticoagulant activities of Certoparin.Approved
NimesulideNimesulide may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
NintedanibThe risk or severity of adverse effects can be increased when Certoparin is combined with Nintedanib.Approved
NitroaspirinNitroaspirin may increase the anticoagulant activities of Certoparin.Investigational
NomegestrolThe therapeutic efficacy of Certoparin can be decreased when used in combination with Nomegestrol.Approved
NorethisteroneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Norethisterone.Approved
NorgestrienoneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Norgestrienone.Experimental
ObinutuzumabThe risk or severity of adverse effects can be increased when Certoparin is combined with Obinutuzumab.Approved, Investigational
OlmesartanCertoparin may increase the hyperkalemic activities of Olmesartan.Approved, Investigational
OlopatadineOlopatadine may increase the anticoagulant activities of Certoparin.Approved
OlsalazineOlsalazine may increase the anticoagulant activities of Certoparin.Approved
Omacetaxine mepesuccinateThe risk or severity of bleeding can be increased when Certoparin is combined with Omacetaxine mepesuccinate.Approved, Investigational
Omega-3 fatty acidsOmega-3 fatty acids may increase the anticoagulant activities of Certoparin.Approved, Nutraceutical
Omega-3-carboxylic acidsThe therapeutic efficacy of Certoparin can be increased when used in combination with Omega-3-carboxylic acids.Approved, Investigational
OrgoteinOrgotein may increase the anticoagulant activities of Certoparin.Vet Approved
OtamixabanOtamixaban may increase the anticoagulant activities of Certoparin.Investigational
OxaprozinOxaprozin may increase the anticoagulant activities of Certoparin.Approved
OxyphenbutazoneOxyphenbutazone may increase the anticoagulant activities of Certoparin.Approved, Withdrawn
OzagrelOzagrel may increase the anticoagulant activities of Certoparin.Investigational
PaliferminThe serum concentration of Palifermin can be increased when it is combined with Certoparin.Approved
ParecoxibParecoxib may increase the anticoagulant activities of Certoparin.Approved
ParnaparinParnaparin may increase the anticoagulant activities of Certoparin.Approved, Investigational
ParthenolideParthenolide may increase the anticoagulant activities of Certoparin.Approved, Investigational
Pentaerythritol TetranitratePentaerythritol Tetranitrate may increase the anticoagulant activities of Certoparin.Approved
Pentosan PolysulfatePentosan Polysulfate may increase the anticoagulant activities of Certoparin.Approved
PentoxifyllinePentoxifylline may increase the anticoagulant activities of Certoparin.Approved, Investigational
PhenindionePhenindione may increase the anticoagulant activities of Certoparin.Approved, Investigational
PhenprocoumonPhenprocoumon may increase the anticoagulant activities of Certoparin.Approved, Investigational
Phenyl aminosalicylatePhenyl aminosalicylate may increase the anticoagulant activities of Certoparin.Approved
PhenylbutazonePhenylbutazone may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
PicotamidePicotamide may increase the anticoagulant activities of Certoparin.Experimental
PimecrolimusPimecrolimus may increase the anticoagulant activities of Certoparin.Approved, Investigational
PirfenidonePirfenidone may increase the anticoagulant activities of Certoparin.Approved, Investigational
PiroxicamPiroxicam may increase the anticoagulant activities of Certoparin.Approved, Investigational
PirprofenPirprofen may increase the anticoagulant activities of Certoparin.Experimental
Polyestradiol phosphatePolyestradiol phosphate may decrease the anticoagulant activities of Certoparin.Approved
PranoprofenPranoprofen may increase the anticoagulant activities of Certoparin.Experimental, Investigational
PrasugrelPrasugrel may increase the anticoagulant activities of Certoparin.Approved
ProgesteroneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Progesterone.Approved, Vet Approved
ProglumetacinProglumetacin may increase the anticoagulant activities of Certoparin.Experimental
PromegestoneThe therapeutic efficacy of Certoparin can be decreased when used in combination with Promegestone.Experimental
PromestrienePromestriene may decrease the anticoagulant activities of Certoparin.Investigational
PropacetamolPropacetamol may increase the anticoagulant activities of Certoparin.Approved, Investigational
PropyphenazonePropyphenazone may increase the anticoagulant activities of Certoparin.Experimental
ProquazoneProquazone may increase the anticoagulant activities of Certoparin.Experimental
Protein CCertoparin may increase the anticoagulant activities of Protein C.Approved
Protein S humanCertoparin may increase the anticoagulant activities of Protein S human.Approved
ProtocatechualdehydeCertoparin may increase the anticoagulant activities of Protocatechualdehyde.Approved
PTC299PTC299 may increase the anticoagulant activities of Certoparin.Investigational
QuinestrolQuinestrol may decrease the anticoagulant activities of Certoparin.Approved
RamatrobanRamatroban may increase the anticoagulant activities of Certoparin.Investigational
RelcovaptanRelcovaptan may increase the anticoagulant activities of Certoparin.Investigational
ResveratrolResveratrol may increase the anticoagulant activities of Certoparin.Approved, Experimental, Investigational
ReteplaseReteplase may increase the anticoagulant activities of Certoparin.Approved, Investigational
ReviparinReviparin may increase the anticoagulant activities of Certoparin.Approved, Investigational
RidogrelRidogrel may increase the anticoagulant activities of Certoparin.Approved
RivaroxabanCertoparin may increase the anticoagulant activities of Rivaroxaban.Approved
RofecoxibRofecoxib may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
RosiglitazoneRosiglitazone may increase the anticoagulant activities of Certoparin.Approved, Investigational
SacubitrilCertoparin may increase the hyperkalemic activities of Sacubitril.Approved
SalicylamideSalicylamide may increase the anticoagulant activities of Certoparin.Approved
Salicylic acidSalicylic acid may increase the anticoagulant activities of Certoparin.Approved, Investigational, Vet Approved
SalsalateSalsalate may increase the anticoagulant activities of Certoparin.Approved
SaprisartanCertoparin may increase the hyperkalemic activities of Saprisartan.Experimental
SaralasinCertoparin may increase the hyperkalemic activities of Saralasin.Investigational
SarpogrelateSarpogrelate may increase the anticoagulant activities of Certoparin.Investigational
SaruplaseSaruplase may increase the anticoagulant activities of Certoparin.Experimental
SecoisolariciresinolSecoisolariciresinol may decrease the anticoagulant activities of Certoparin.Investigational
SelexipagSelexipag may increase the anticoagulant activities of Certoparin.Approved
SemapimodSemapimod may increase the anticoagulant activities of Certoparin.Investigational
SeratrodastSeratrodast may increase the anticoagulant activities of Certoparin.Approved
SerrapeptaseSerrapeptase may increase the anticoagulant activities of Certoparin.Investigational
SevofluraneSevoflurane may increase the anticoagulant activities of Certoparin.Approved, Vet Approved
SpironolactoneCertoparin may increase the hyperkalemic activities of Spironolactone.Approved
SRT501SRT501 may increase the anticoagulant activities of Certoparin.Investigational
StreptokinaseStreptokinase may increase the anticoagulant activities of Certoparin.Approved, Investigational
SugammadexSugammadex may increase the anticoagulant activities of Certoparin.Approved
SulfasalazineSulfasalazine may increase the anticoagulant activities of Certoparin.Approved
SulindacSulindac may increase the anticoagulant activities of Certoparin.Approved, Investigational
SulodexideSulodexide may increase the anticoagulant activities of Certoparin.Approved, Investigational
SuprofenSuprofen may increase the anticoagulant activities of Certoparin.Approved, Withdrawn
SuxibuzoneSuxibuzone may increase the anticoagulant activities of Certoparin.Experimental
Synthetic Conjugated Estrogens, ASynthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Certoparin.Approved
Synthetic Conjugated Estrogens, BSynthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Certoparin.Approved
TarenflurbilTarenflurbil may increase the anticoagulant activities of Certoparin.Investigational
TasosartanCertoparin may increase the hyperkalemic activities of Tasosartan.Approved
TelmisartanCertoparin may increase the hyperkalemic activities of Telmisartan.Approved, Investigational
TenecteplaseTenecteplase may increase the anticoagulant activities of Certoparin.Approved
TenidapTenidap may increase the anticoagulant activities of Certoparin.Experimental
TenoxicamTenoxicam may increase the anticoagulant activities of Certoparin.Approved
TepoxalinTepoxalin may increase the anticoagulant activities of Certoparin.Vet Approved
TeriflunomideTeriflunomide may increase the anticoagulant activities of Certoparin.Approved
TesmilifeneTesmilifene may increase the anticoagulant activities of Certoparin.Investigational
Testosterone cypionateThe therapeutic efficacy of Certoparin can be increased when used in combination with Testosterone cypionate.Approved
Testosterone enanthateThe therapeutic efficacy of Certoparin can be increased when used in combination with Testosterone enanthate.Approved
Testosterone undecanoateThe therapeutic efficacy of Certoparin can be increased when used in combination with Testosterone undecanoate.Approved, Investigational
Tiaprofenic acidTiaprofenic acid may increase the anticoagulant activities of Certoparin.Approved
TiboloneTibolone may increase the anticoagulant activities of Certoparin.Approved, Investigational
TicagrelorTicagrelor may increase the anticoagulant activities of Certoparin.Approved
TiclopidineTiclopidine may increase the anticoagulant activities of Certoparin.Approved
TinoridineTinoridine may increase the anticoagulant activities of Certoparin.Investigational
TinzaparinTinzaparin may increase the anticoagulant activities of Certoparin.Approved
TioclomarolTioclomarol may increase the anticoagulant activities of Certoparin.Experimental
TipranavirTipranavir may increase the anticoagulant activities of Certoparin.Approved, Investigational
TirofibanTirofiban may increase the anticoagulant activities of Certoparin.Approved
Tolfenamic AcidTolfenamic Acid may increase the anticoagulant activities of Certoparin.Approved, Investigational
TolmetinTolmetin may increase the anticoagulant activities of Certoparin.Approved
TositumomabThe risk or severity of adverse effects can be increased when Certoparin is combined with Tositumomab.Approved, Investigational
TranilastTranilast may increase the anticoagulant activities of Certoparin.Approved, Investigational
TrapidilTrapidil may increase the anticoagulant activities of Certoparin.Approved
TreprostinilTreprostinil may increase the anticoagulant activities of Certoparin.Approved, Investigational
TriamtereneCertoparin may increase the hyperkalemic activities of Triamterene.Approved
TribenosideTribenoside may increase the anticoagulant activities of Certoparin.Experimental
TriflusalTriflusal may increase the anticoagulant activities of Certoparin.Approved, Investigational
TriptolideTriptolide may increase the anticoagulant activities of Certoparin.Investigational
Trolamine salicylateTrolamine salicylate may increase the anticoagulant activities of Certoparin.Approved
TroxerutinCertoparin may increase the anticoagulant activities of Troxerutin.Investigational
UrokinaseUrokinase may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
ValdecoxibValdecoxib may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
ValsartanCertoparin may increase the hyperkalemic activities of Valsartan.Approved, Investigational
Vitamin EVitamin E may increase the anticoagulant activities of Certoparin.Approved, Nutraceutical, Vet Approved
VorapaxarThe risk or severity of adverse effects can be increased when Vorapaxar is combined with Certoparin.Approved
WarfarinWarfarin may increase the anticoagulant activities of Certoparin.Approved
XimelagatranXimelagatran may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
ZaltoprofenZaltoprofen may increase the anticoagulant activities of Certoparin.Approved, Investigational
ZeranolZeranol may decrease the anticoagulant activities of Certoparin.Vet Approved
ZileutonZileuton may increase the anticoagulant activities of Certoparin.Approved, Investigational, Withdrawn
ZomepiracZomepirac may increase the anticoagulant activities of Certoparin.Withdrawn
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347910425
Wikipedia
Certoparin_sodium

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedPreventionRenal Dialysis1
3CompletedPreventionSystemic Embolism1
3CompletedPreventionThromboembolism1
3CompletedTreatmentPersistent Nonvalvular Atrial Fibrillation1
3TerminatedTreatmentNeoplasms / Venous Thromboembolism1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on October 26, 2015 11:10 / Updated on May 01, 2018 23:58